Literature DB >> 23398871

How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy.

John G Bartlett1.   

Abstract

Anaerobic bacteria are infrequent pulmonary pathogens, and, even then they are, they are almost never recovered due to the need for specimens uncontaminated by the upper airway flora and failure to do adequate anaerobic bacteriology. These bacteria are relatively common in selected types of lung infections including aspiration pneumonia, lung abscess, necrotizing pneumonia and emphyema. Preferred antibiotics for these infections based on clinical experience are clindamycin and any betalactam-betalactamase inhibitor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398871     DOI: 10.1016/j.idc.2012.11.016

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  16 in total

Review 1.  Lung abscess-etiology, diagnostic and treatment options.

Authors:  Ivan Kuhajda; Konstantinos Zarogoulidis; Katerina Tsirgogianni; Drosos Tsavlis; Ioannis Kioumis; Christoforos Kosmidis; Kosmas Tsakiridis; Andrew Mpakas; Paul Zarogoulidis; Athanasios Zissimopoulos; Dimitris Baloukas; Danijela Kuhajda
Journal:  Ann Transl Med       Date:  2015-08

2.  Empyema caused by Anaeroglobus geminates, a case report with literature review.

Authors:  C-H Wang; L-P Kan; J-R Sun; C-M Yu; T Yin; T-W Huang; W-C Tsai; Y-S Yang
Journal:  Infection       Date:  2014-08-26       Impact factor: 3.553

Review 3.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 4.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

5.  Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis.

Authors:  Małgorzata Benedyk; Piotr Mateusz Mydel; Nicolas Delaleu; Karolina Płaza; Katarzyna Gawron; Aleksandra Milewska; Katarzyna Maresz; Joanna Koziel; Krzysztof Pyrc; Jan Potempa
Journal:  J Innate Immun       Date:  2015-11-28       Impact factor: 7.349

6.  Association between swallowing function and oral bacterial flora in independent community-dwelling elderly.

Authors:  Yoshimi Hida; Tomoko Nishida; Chie Taniguchi; Hisataka Sakakibara
Journal:  Aging Clin Exp Res       Date:  2020-03-09       Impact factor: 3.636

7.  Bacteriology of aspiration pneumonia in patients with acute coma.

Authors:  Enise Lauterbach; Frederik Voss; Roland Gerigk; Michael Lauterbach
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

8.  Oral and endotracheal tubes colonization by periodontal bacteria: a case-control ICU study.

Authors:  A N Porto; S C Cortelli; A H Borges; F Z Matos; D R Aquino; T B Miranda; F Oliveira Costa; A F Aranha; J R Cortelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

Review 9.  When does nutrition impact respiratory function?

Authors:  Karen S Allen; Ishan Mehta; Rodrigo Cavallazzi
Journal:  Curr Gastroenterol Rep       Date:  2013-06

10.  Temporal airway microbiome changes related to ventilator-associated pneumonia in children.

Authors:  Peter M Mourani; Marci K Sontag; Kayla M Williamson; J Kirk Harris; Ron Reeder; Chris Locandro; Todd C Carpenter; Aline B Maddux; Katherine Ziegler; Eric A F Simões; Christina M Osborne; Lilliam Ambroggio; Matthew K Leroue; Charles E Robertson; Charles Langelier; Joseph L DeRisi; Jack Kamm; Mark W Hall; Athena F Zuppa; Joseph Carcillo; Kathleen Meert; Anil Sapru; Murray M Pollack; Patrick McQuillen; Daniel A Notterman; J Michael Dean; Brandie D Wagner
Journal:  Eur Respir J       Date:  2021-03-18       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.